Healthcare investor
Aman Mahajan, MD, PhD
Partner
Healthier Capital
Aman Mahajan is a physician-scientist and a partner at Healthier Capital. An anesthesiologist trained at UCLA, he chaired anesthesiology departments at UCLA Health and the University of Pittsburgh Medical Center (UPMC) and later led health innovation and venture investing at UPMC.
Training and Leadership at UCLA
Mahajan did his medical specialty training in anesthesiology, a cardiac fellowship, and his PhD at UCLA, and he holds an MBA from the University of Massachusetts, according to his Healthier Capital profile. He became an endowed professor and chair of the Department of Anesthesiology at UCLA Health and taught the Business of Healthcare MBA course at the UCLA Anderson School of Management.
Innovation and Investing at UPMC
At UPMC he held the Peter Safar Endowed Chair of Anesthesiology and Perioperative Medicine and ran perioperative services, and as senior vice president of health innovation he guided innovation, commercialization, and venture investments. He held professorships in medicine, biomedical informatics, and bioengineering, and his research on health care technology has been funded by multiple NIH awards.
Joining Suki's Board
Healthier Capital led the $90 million Series E of Suki, the ambient clinical AI company, in October 2026, and Mahajan joined Suki's board. “The real opportunity for AI in healthcare isn't to automate individual tasks. It's to rethink how work gets done across the health system,” he said in the announcement.